Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.4 | 1.4 | 1.4 | 0 | 0 | CS |
4 | 0 | 0 | 1.4 | 1.4 | 1.4 | 0 | 0 | CS |
12 | 0 | 0 | 1.4 | 1.4 | 1.4 | 0 | 0 | CS |
26 | -13.72 | -90.7407407407 | 15.12 | 18.42 | 1.4 | 111517 | 15.99405801 | CS |
52 | -16.96 | -92.3747276688 | 18.36 | 19.62 | 1.4 | 203051 | 16.27273216 | CS |
156 | -71.2 | -98.0716253444 | 72.6 | 79.44 | 1.4 | 645032 | 18.10171605 | CS |
260 | -216.4 | -99.3572084481 | 217.8 | 351.84 | 1.4 | 529348 | 58.80724878 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.